The Coca-Cola Company has signed licensing agreement that will let Frutura’d Dayka & Hackett (D&H) use Minute Maid and Simply brands on fresh fruit for the first time.
Products bearing Minute Maid and Simply Select imagery will begin appearing in D&H’s existing brand portfolio at retail in the second quarter of 2023.
Simply Select will initially be used on D&H fresh citrus sold in the US, while the Minute Maid brand will be used on D&H grapes in the US and on D&H fresh citrus and grapes sold in Japan.
D&H is a California-based grower, packer, and distributor of premium fruit.
According to Kayla Carlucci, associate licensing manager with The Coca-Cola Company, the quality of the product that will bear the Coca-Cola name is paramount as is the quality control the licensee exercises at every step along the supply chain.
D&H CEO Tim Dayka, who crafted the licensing agreement on Frutura’s behalf, described the deal as a transformative moment for their company and Frutura, allowing them to increase their market penetration in a meaningful way, as the Minute Maid and Simply brands resonate so strongly with consumers.


Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Asian Markets Mixed as Fed Rate Cut Bets Grow and Japan’s Nikkei Leads Gains
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
The Beauty Beneath the Expressway: A Journey from Self to Service
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Why have so few atrocities ever been recognised as genocide? 



